戻る Agenda
Session 6 Track 3: The Art of Medical Science Liaising – How is the Canvas Changing
Session Chair(s)
J. Lynn Bass, PharmD, RPh
Senior Director, Medical Science Liaisons
BridgeBio, United States
Donna Booth, PharmD
Head, Field Medical Accounts-East, US Medical Affairs
GlaxoSmithKline, United States
The field based medical affairs teams serve as conduits of medical and scientific information and are positioned at the heart of pharma’s network of thought leaders and other experts. However, it has been difficult to realize the true impact of their field activities. In this session, we will evaluate the impact of two specific areas of interest - through expanding career opportunities for individuals along with expanding the base of customer segments. Each of these will provide insight into future methods to assess impact of these important roles.
Learning Objective : At the conclusion of this session, participants should be able to:
- Describe new and expanded customer segments for field medical affairs
- Examine the impact and value to the company resulting from interactions with these new customer segments
- Review potential career paths for field medical affairs and how this career path adds value to both the individual and the company
Speaker(s)
Speaker
Jeff Vaughan, PharmD, MS
Ashfield Engage, United States
National Director, Field Medical Science
Speaker
Rachel Couchenour, PharmD, MBA
Travere Therapeutics, United States
VP, Head of Medical Affairs